Aurobindo Pharma gets final approval for Abacavir Sulfate and Lamivudine Tablets

Image
Capital Market
Last Updated : Mar 30 2017 | 11:01 AM IST

From USFDA

Aurobindo Pharma announced that the Company has received final approval from the US Food & Drugs Administration to manufacture Abacavir Sulfate and Lamivudine Tablets, 600 mg/ 300 mg. Aurobindo's Abacavir Sulfate and Lamivudine Tablets are the AB rated generic equivalent of VIIV Healthcare Company's Epzicom Tablets. The product is being launched immediately.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Mar 30 2017 | 10:20 AM IST

Next Story